Co-Authors
This is a "connection" page, showing publications co-authored by Hadi Manji and Michael Zandi.
Connection Strength
0.748
-
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020 10 01; 143(10):3104-3120.
Score: 0.226
-
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. EClinicalMedicine. 2021 Sep; 39:101070.
Score: 0.060
-
Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. J Neurol Sci. 2021 09 15; 428:117608.
Score: 0.060
-
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study. Brain Commun. 2021; 3(3):fcab168.
Score: 0.060
-
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun. 2021; 3(3):fcab099.
Score: 0.059
-
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 03 03; 144(2):682-693.
Score: 0.058
-
Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe? Brain. 2020 12 01; 143(12):e101.
Score: 0.057
-
Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):1013-1014.
Score: 0.056
-
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020 10; 7(10):875-882.
Score: 0.056
-
Defining causality in COVID-19 and neurological disorders. J Neurol Neurosurg Psychiatry. 2020 08; 91(8):811-812.
Score: 0.055